Predictions
Hexo Corp.
Start price
Target price
Perf. (%)
€93.80
19.02.21
19.02.21
€210.00
19.02.22
19.02.22
-66.72%
23.08.21
23.08.21
Could be worthwhile Investment >10% per year
Pixium Vision S.A.
Start price
Target price
Perf. (%)
€1.03
17.02.21
17.02.21
€3.00
17.02.22
17.02.22
-24.32%
25.12.21
25.12.21
Could be very worthwhile Investment >20% year
Leading role in innovation
Future proof or reliable business model
Nanorepro AG
Start price
Target price
Perf. (%)
€8.95
16.02.21
16.02.21
€5.00
16.02.22
16.02.22
-7.49%
18.10.21
18.10.21
Below average Management
Little innovation
Few uniques
Dependend from some customers or products
Perrigo Co. plc
Start price
Target price
Perf. (%)
€37.00
15.02.21
15.02.21
-
15.02.22
15.02.22
5.95%
11.07.21
11.07.21
Could be worthwhile Investment >10% per year
Undervalued
Higher risks for its business
Viatris Inc.
Start price
Target price
Perf. (%)
€15.40
15.02.21
15.02.21
€19.00
15.02.22
15.02.22
-14.92%
15.02.22
15.02.22
Undervalued
High dividend yield expected
Nanorepro AG
Start price
Target price
Perf. (%)
€8.60
15.02.21
15.02.21
€20.00
15.02.22
15.02.22
5.47%
23.09.21
23.09.21
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
LexaGene Holdings Inc.
Start price
Target price
Perf. (%)
€0.92
11.02.21
11.02.21
€2.00
11.02.22
11.02.22
-52.92%
20.04.21
20.04.21
Aphria Inc.
Start price
Target price
Perf. (%)
€20.95
10.02.21
10.02.21
€22.00
11.75%
11.02.21
11.02.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Dexcom Inc.
Start price
Target price
Perf. (%)
€82.24
09.02.21
09.02.21
€87.50
09.02.22
09.02.22
29.20%
12.08.21
12.08.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Sustainability is important
Higher risks for its business
Clinuvel Pharmaceuticals
Start price
Target price
Perf. (%)
€13.90
09.02.21
09.02.21
-
09.02.22
09.02.22
10.47%
10.02.22
10.02.22
Fair valuation
Dependend from few customers or products
Heat Biologics Inc.
Start price
Target price
Perf. (%)
€11.10
09.02.21
09.02.21
-
09.02.22
09.02.22
-41.26%
07.03.21
07.03.21
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Some uniques
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€34.83
08.02.21
08.02.21
€41.00
16.07.21
16.07.21
27.92%
16.07.21
16.07.21
Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital
CRH Medical Corp
Start price
Target price
Perf. (%)
€3.22
08.02.21
08.02.21
€3.00
08.02.22
08.02.22
-0.62%
22.02.21
22.02.21
Good culture
Probably not worthwhile Investment
Little innovation
No uniques
Atossa Genetics Inc
Start price
Target price
Perf. (%)
€3.44
08.02.21
08.02.21
€5.00
08.02.22
08.02.22
-27.31%
22.02.21
22.02.21
Could be worthwhile Investment >10% per year
Star Equity Holdings Inc.
Start price
Target price
Perf. (%)
€3.12
08.02.21
08.02.21
€5.00
08.02.22
08.02.22
14.10%
22.02.21
22.02.21
Could be worthwhile Investment >10% per year
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€32.25
08.02.21
08.02.21
€50.00
08.02.22
08.02.22
6.98%
22.02.21
22.02.21
Could be worthwhile Investment >10% per year
Nuwellis Inc.
Start price
Target price
Perf. (%)
€7.35
08.02.21
08.02.21
€9.00
08.02.22
08.02.22
-1.36%
22.02.21
22.02.21
Could be very worthwhile Investment >20% year